Albert Brzeczko - Acura Pharmaceuticals Insider

Acura Pharmaceuticals Inc -- USA Stock  

USD 0.44  0.0272  6.59%

VP of Technical Affairs

Dr. Albert W. Brzeczko Ph.D. serves as an Vice President, Technical Affairs of Acura Pharmaceutical Technologies, Inc. since February 2009. From 1999 through 2009, Dr. Brzeczko was Vice President, Global Pharma New Product Development and Pharma Technologies for International Specialty Products, Inc., a contract services group specializing in the development of technologies for the bioenhancement of poorly soluble drugs. Prior to 1999, Dr. Brzeczko held various positions of increasing responsibility in pharmaceutical product development with UPM Pharmaceuticals, Banner Pharmacaps, Mylan Laboratories, and DuPont Merck
Age: 59  VP Since 2009  Ph.D    
847 705-7709  www.acurapharm.com
Brzeczko received a BS degree in biochemistry and a Ph.D. in pharmaceutical sciences from the University of Maryland.

Albert Brzeczko Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (13.28) % which means that it has lost $13.28 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (373.58) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 4.29 M in liabilities with Debt to Equity (D/E) ratio of 288.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Acura Pharmaceuticals Inc has Current Ratio of 0.91 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Similar Executives

Found 2 records

VP Since

Naamit SherVascular Biogenics Ltd
2006
Marc KirchmeierVBI Vaccines Inc
N/A

Entity Summary

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, researches, develops, and commercializes solutions to address medication abuse and misuse. Acura Pharmaceuticals Inc (ACUR) is traded on OTC Market in USA. It is located in ILLINOIS, U.S.A and employs 15 people. Acura Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Acura Pharmaceuticals Inc to your portfolio

Top Management

Acura Pharmaceuticals Inc Leadership Team

Stock Performance

Acura Pharmaceuticals Performance Indicators